专题:Liver Disease Diagnosis and Treatment

This cluster of papers focuses on the epidemiology, diagnosis, management, and pathogenesis of Nonalcoholic Fatty Liver Disease (NAFLD). It covers topics such as liver fibrosis, insulin resistance, hepatic steatosis, metabolic syndrome, nonalcoholic steatohepatitis (NASH), and non-invasive assessment methods. The papers also discuss the association of NAFLD with hepatocellular carcinoma and its impact on public health.
最新文献
Steatosis grade and cardiometabolic burden as determinants of hepatocellular carcinoma risk after hepatitis C cure in patients with metabolic dysfunction-associated steatotic liver disease

article Full Text OpenAlex

Metabolic dysfunction-associated steatotic liver disease and adverse pregnancy outcomes: a nationwide cohort study

article Full Text OpenAlex

Metabolic Dysfunction‐Associated Steatotic Liver Disease ( MASLD ): Mechanisms, Clinical Implications and Therapeutic Advances

article Full Text OpenAlex

The Gut‒Liver Axis in Liver Disease: Molecular Mechanisms and Therapeutic Targets

article Full Text OpenAlex

Non-invasive liver fibrosis screening and referral patterns in women with dependence due to psychoactive substance use: A single-centre retrospective study

article Full Text OpenAlex

Potential Effects of Functional Foods and Dietary Supplements on Metabolic-Associated Fatty Liver Disease and the Underlying Mechanisms: A Narrative Review with a Focus on the Modulation of the Gut Microbiota

review Full Text OpenAlex

Metabolic Dysfunction–Associated Steatotic Liver Disease in Adults

article Full Text OpenAlex

Constituents-composed Chinese medicine of Dajianzhong Decoction ameliorates Non-alcoholic fatty liver disease via AMPK/PPARα/CPT1 signaling

article Full Text OpenAlex

Semaglutide therapy for metabolic dysfunction–associated steatohepatitis: November 2025 updates to AASLD Practice Guidance

article Full Text OpenAlex

Pathophysiology and emerging biomarkers of cardiovascular-renal-hepato-metabolic syndrome

article Full Text OpenAlex

近5年高被引文献
A multisociety Delphi consensus statement on new fatty liver disease nomenclature

article Full Text OpenAlex 2601 FWCI566.5327

The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review

review Full Text OpenAlex 2595 FWCI568.493

A multisociety Delphi consensus statement on new fatty liver disease nomenclature

review Full Text OpenAlex 2430 FWCI530.1579

Hepatocellular carcinoma

review Full Text OpenAlex 2095 FWCI278.9293

AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease

article Full Text OpenAlex 2011 FWCI437.5872

The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis

review Full Text OpenAlex 1971 FWCI293.3355

Global burden of primary liver cancer in 2020 and predictions to 2040

article Full Text OpenAlex 1858 FWCI267.9297

Global burden of liver disease: 2023 update

review Full Text OpenAlex 1764 FWCI383.7872

A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis

article Full Text OpenAlex 1461 FWCI580.1987

AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma

article Full Text OpenAlex 1450 FWCI299.7986